TZP Strategies Acquisition Corp.: Nasdaq/NYSE listing notice — TZP Strategies Acquisition Corp. to redeem shares and delist after failing to complete business combination

TZP Strategies Acquisition Corp.

Received Nasdaq delisting notice on Jan 9, 2023 for failure to hold annual meeting; 45 days to submit compliance plan.
Announced Jan 6, 2023 redemption of all Class A ordinary shares effective Jan 23, 2023 due to inability to complete initial business combination.
Nasdaq expected to file Form 25 to delist securities after Jan 20, 2023.
Company will not consummate an initial business combination, effectively liquidating.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.98

TZP Strategies Acquisition Corp. received a nasdaq deficiency notice notice regarding other (rules 5620(a), 5810(c)(2)(G)).

Exchange: nasdaq
Notice: deficiency notice
Rules: 5620(a), 5810(c)(2)(G)

Exact text from the filing

January 9, 2023, TZP Strategies Acquisition Corp. (the “ Company ”) received a notice from the Listing Qualifications Department of The Nasdaq Stock Market (“ Nasdaq ”) stating that the Company failed to hold an annual meeting of stockholders within 12 months after its fiscal year ended December 31, 2021, as required by Nasdaq Listing Rule 5620(a). In accordance with Nasdaq Listing Rule 5810(c)(2)(G), the Company has 45 calendar days (or until February 23, 2023) to submit a plan to regain compliance and, if Nasdaq accepts the plan, Nasdaq may grant the Company up to 180 calendar days from its

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001193125-23-008331

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.